REX:NYE-REX American Resources Corporation (USD)

COMMON STOCK | Chemicals |

Last Closing

USD 46.12

Change

0.00 (0.00)%

Market Cap

N/A

Volume

0.14M

Analyst Target

USD 95.00
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-28 )

Largest Industry Peers for Chemicals

Symbol Name Price(Change) Market Cap
HUN Huntsman Corporation

N/A

USD 3.90B
BAK Braskem SA Class A

N/A

USD 2.97B
TROX Tronox Holdings PLC

N/A

USD 2.30B
VHI Valhi Inc

N/A

USD 0.83B
ASIX AdvanSix Inc

N/A

USD 0.82B
WLKP Westlake Chemical Partners LP

N/A

USD 0.79B
RYAM Rayonier Advanced Materials

N/A

USD 0.56B
DOW Dow Inc

N/A

N/A
CE Celanese Corporation

N/A

N/A
LXU Lsb Industries Inc

N/A

N/A

ETFs Containing REX

PUW 0.00 % 0.70 %

N/A

N/A
SIXS 6 Meridian Small Cap Equi.. 0.00 % 0.00 %

N/A

USD 0.09B

Market Performance

  Market Performance vs. Industry/Classification (Chemicals) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -85.48% 9% A- 2% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -85.48% 9% A- 2% F
Trailing 12 Months  
Capital Gain -83.14% 9% A- 2% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -83.14% 9% A- 2% F
Trailing 5 Years  
Capital Gain -73.01% 18% F 6% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return -73.01% 18% F 6% D-
Average Annual (5 Year Horizon)  
Capital Gain 20.18% N/A N/A 83% B
Dividend Return 20.18% N/A N/A 81% B-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 28.67% N/A N/A 36% F
Risk Adjusted Return 70.37% N/A N/A 84% B
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:

There is nothing we particularly dislike